…triuretic peptide (−67% vs −21% vs −32%, p=0.004) compared with PDE5i monotherapy and riociguat monotherapy. These differences persis…
4articles mentioning drugs
14drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: PDE5i ×
PDE5i
This drug is selected. Its supporting articles are shown below.
Articles mentioning PDE5i
4 articles · page 1 of 1PDE5iriociguatERAendothelin receptor antagonistRoyal Papworth HospitalCTEPHchronic thromboembolic PH (CTEPH)Pulmonary hypertensionBPA
riociguatPDE5iERANT-proBNPendothelin receptor antagonistsRoyal Papworth HospitalCTEPHchronic thromboembolic pulmonary hypertension
…herapy, 67 received PDE5i and ERA dual therapy, and 49 received riociguat monotherapy. Patients with more severe baseline haemodynamic da…
bosentanVVDPDE5iERAsprostanoidsRaynaud’s phenomenon
… 0.652), but not in those without DU. The protective effects of bosentan were confirmed in all sensitivity analyses targeting PAH detect…
Mycophenolate MofetilMMFiloprostPDE5iMMF-treatedERAsystemic sclerosis (SSc)interstitial lung diseaseinterstitial lung disease (ILD)cutaneous fibrosis+1 more
…Introduction The prescription of Mycophenolate Mofetil (MMF) represents the primary treatment for interstitial lung di…